Company and Case Information

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors


Register


_______________
Copyright (c) 2001
Stanford Law School


Sanofi-Aventis
Summary: According to a law firm press release, a class action was filed against Sanofi-Aventis on November 13, 2007.

The complaint charges Sanofi and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Sanofi-Aventis engages in the research, development, manufacture, and marketing of healthcare products worldwide.

Sanofi is the third largest pharmaceutical company in the world. According to the complaint, in 2002, Sanofi began testing a new drug, Zimulti, which is designed to fight obesity by reducing appetite. As the first drug of its class, Zimulti was projected to become extremely profitable for Sanofi. Sanofi submitted its New Drug Application (“NDA”) for Zimulti in April 2005 and on June 23, 2005, the Company announced that the Food and Drug Administration (“FDA”) had accepted it for filing. The complaint alleges that defendants’ statements regarding Zimulti were materially false and misleading when made because defendants concealed data concerning Zimulti’s propensity to cause depression.

On June 13, 2007, the committee met and made a unanimous decision that Zimulti could not be recommended for approval. After the FDA’s decision on June 13, 2007, Sanofi’s securities declined $1.87, or 4.16%, closing at $43.07 on heavy trading volume.

On February 29,2008, Order Appointing The Global, Funds As Lead Plaintiff And Approving Lead Plaintiff's Selection Of Lead Counsel. On April 29, 2008, a Consolidated Complaint For Violations Of Securities Laws was filed with the court by the lead plaintiffs.

On September 26, 2009, Defendants motion to dismiss plaintiffs' claims pursuant to Fed. R. Civ. P. 12(b)(6) was granted pursuant to the Court's Memorandum Opinion and Order dated September 25, 2009.

INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Major Drugs


COMPANY/ISSUER NAME: Sanofi-Aventis
COMPANY/ISSUER TICKER: SNY
COMPANY WEBSITE: http://www.sanofi-aventis.com

FIRST IDENTIFIED COMPLAINT IN THE DATABASE
City of Taylor General Employees Retirement System, et al. v. Sanofi-Aventis, et al.
 COURT: S.D. New York  DOCKET NUMBER: 07-CV-10279
 JUDGE NAME: Hon. George B. Daniels
 DATE FILED: 11/13/2007  SOURCE: Notice of Filing
 CLASS PERIOD START: 02/17/2006  CLASS PERIOD END: 06/13/2007
 TYPE OF COMPLAINT: Complaint (Unamended and Unconsolidated)
 PLAINTIFF FIRMS NAMED IN COMPLAINT:
  • Coughlin Stoia Geller Rudman & Robbins LLP (Melville)
      200 Broadhollow, Suite 406, Melville, NY, 11747
       (voice) 631.367.7100, (fax) 631.367.1173, info@csgrr.com/
  • Stull, Stull & Brody (New York)
      6 East 45th Street, New York, NY, 10017
       (voice) 310.209.2468, (fax) 310.209.2087, SSBNY@aol.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  2

  •  DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
    Complaint For Violation Of The Federal Securities Laws
    Type: Complaint Date on the document: 11/13/2007
    Order Appointing The Global, Funds As Lead Plaintiff And Approving Lead Plaintiff's Selection Of Lead Counsel.
    Type: Order Appointing LP/LC Date on the document: 02/29/2008

    REFERENCE COMPLAINT
    In re Sanofi-Aventis Securities Litigation
     COURT: S.D. New York  DOCKET NUMBER: 07-CV-10279
     JUDGE NAME: Hon. George B. Daniels
     DATE FILED: 04/29/2008  SOURCE: Docket
     CLASS PERIOD START: 03/01/2005  CLASS PERIOD END: 06/13/2007
     TYPE OF COMPLAINT: First Consolidated
     PLAINTIFF FIRMS NAMED IN COMPLAINT:
  • Coughlin Stoia Geller Rudman & Robbins LLP (Melville)
      58 South Service Road, Suite 200, Melville, NY, 11747
       (voice) 631.367.7100, (fax) 631.367.1173, info@csgrr.com/
  • Coughlin Stoia Geller Rudman & Robbins LLP (San Diego)
      655 West Broadway, Suite 1900, San Diego, CA, 92101
       (voice) 619.231.1058, (fax) 619.231.7423, info@csgrr.com/
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  2

  •  DOCUMENTS FOR THE REFERENCE COMPLAINT
    Consolidated Complaint For Violations Of Securities Laws
    Type: Complaint Date on the document: 04/29/2008
    Memorandum Opinion And Order
    Type: Order Date on the document: 09/25/2009
    Judgment
    Type: Other Date on the document: 09/26/2009
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 09/26/2009

     OTHER DOCUMENTS
    Case Name and/or Number: 
    Type:  Date on the document: 

    WARNING AND DISCLAIMER OF LIABILITY:
    The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
    Go to Search  page | Go to Case Index  page | Back to Top